The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Mon., Jul. 27, 9:25 PM

Slide #3. Egalet Corporation Secondary Offering

Company: Egalet Corporation (NASDAQ:EGLT)
Date announced: 7/27/2015
Secondary Offering Details: Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. Stifel and Guggenheim Securities are acting as joint bookrunning managers for the offering. In connection with this offering, Egalet expects to grant the underwriters a 30-day option to purchase additional shares of common stock, equal to up to 15% of the number of shares of common stock sold in the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares in the offering are to be sold by Egalet.

Egalet is a pharmaceutical company developing abuse-deterrent oral products for the treatment of pain and in other indications. Co.'s principal product candidate, Egalet-001, is an abuse-deterrent, extended-release, oral morphine formulation in development for the treatment of moderate to severe pain. Co.'s second product candidate, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation in development for the treatment of moderate to severe pain. In addition to Co.'s two clinical-stage product candidates, Co. is also developing a portfolio of preclinical, abuse-deterrent product candidates for the treatment of pain and in other indications.
Open the EGLT Page at The Online Investor »

Company Name:  Egalet Corp
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding EGLT:  1
Total Market Value Held by ETFs:  $186985
Total Market Capitalization:  $211.00M
% of Market Cap. Held by ETFs:  0.09%

Open the EGLT Page at The Online Investor (in a new window) »

July 27, 2015    9:25 PM Eastern
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.